Lantern Pharma: Funding, Investors & Team (Oct 2026)
Lantern Pharma, Inc. is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action. Lantern also rescues and revitalizes abandoned or failed cancer drugs using machine learning techniques, genomic data and precision oncology trials. Lantern Pharma recognizes that the high cost and low success rates in oncology drug development largely stem from the inability to appropriately stratify patient populations prior to enrollment, and also from the inability to fully elucidate mechanisms of action that can suggest potent therapy combinations. Our approach, which leverages our RADR™ platform helps to provide rapid, meaningful insight to both of these central problems in oncology. Lantern is focused on accelerating personalized cancer therapy development through the use of AI and genomic-based patient stratification.
Lantern Pharma has raised $4.4M across 1 funding round on record, the most recent an undisclosed round of $4.4M announced in May 2026.
That round is below the $6.0M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Lantern Pharma Company Profile and Key Stats
Latest funding round on record: May 2026.
Lantern Pharma Funding Rounds
Lantern Pharma Founders and Leadership Team
Contact details for the Lantern Pharma team: 1 has a LinkedIn profile.
Start 14-day free trial →Lantern Pharma Funding Compared to Other Artificial Intelligence Startups
Lantern Pharma's latest round of $4.4M is below the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Lantern Pharma in Artificial Intelligence and Dallas
Companies Similar to Lantern Pharma
Gallatin is developing a logistics system that is tailored to the current requirements and limitations of the…
Nyne is the people data company. We deploy tens of millions of autonomous agents across the open web to…
Vinci utilizes generative artificial intelligence to create hardware design. Its services cover the design,…
Siena AI is an innovative customer service platform designed specifically for commerce. It combines the…
Factory is a developer of an AI-based platform for computer codes and software engineering. Its platform…
Ocular is a Cloud and Artificial Intelligence company, backed by Y Combinator, bringing Enterprise AI and…
Ghost is a consumer hardware and software company building a private, local-first computing system for…
Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial…
The EnCharge AI platform provides a reliable computing solution that enables the utilization of highly…
The hardest unsolved problem in robotics isn't perception or locomotion, it's dexterity. Tangent Robotics…
Autopoiesis Sciences creates advanced AI models that aim to enable groundbreaking scientific advancements…
Lantern Pharma Funding FAQs
What does Lantern Pharma do?
Lantern Pharma, Inc. is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action. Lantern also rescues and revitalizes abandoned or failed cancer drugs using machine learning techniques, genomic data and precision oncology trials. Lantern Pharma recognizes that the high cost and low success rates in oncology drug development largely stem from the inability to appropriately stratify patient populations prior to enrollment, and also from the inability to fully elucidate mechanisms of action that can suggest potent therapy combinations. Our approach, which leverages our RADR™ platform helps to provide rapid, meaningful insight to both of these central problems in oncology. Lantern is focused on accelerating personalized cancer therapy development through the use of AI and genomic-based patient stratification.
How much funding has Lantern Pharma raised?
Lantern Pharma has raised $4.4M across 1 round on record. The most recent is an undisclosed round of $4.4M announced in May 2026.
When did Lantern Pharma last raise funding?
Lantern Pharma's most recent funding round on record is an undisclosed round of $4.4M, announced in May 2026.
Who founded Lantern Pharma?
FundedIQ lists Panna Sharma (Founder) at Lantern Pharma.
Where is Lantern Pharma headquartered?
Lantern Pharma is based in Dallas, Texas, United States.
How many employees does Lantern Pharma have?
Lantern Pharma is in the 11-50 employee band.
How does Lantern Pharma's funding compare to other Artificial Intelligence startups?
Lantern Pharma's latest round of $4.4M is below the $6.0M median round size for Artificial Intelligence companies on FundedIQ across 7,241 tracked companies over the last two years.
About FundedIQ's Lantern Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Lantern Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.